- Home
- Agriculture
- IHC and ISH slide staining system Market
IHC and ISH slide staining system Market Size, Share & Trends Estimation Report By Type Outlook (Systems, Accessories, Consumables, Reagents), By Application Outlook (Drug Manufacturing, Pathology Research, Disease Detection), Region and Forecasts, 2022 - 2030
Market Overview
Global IHC And ISH Slide Staining System Market size was valued at USD 4.3 Billion in 2022 and is projected to reach USD 7.2 Billion by 2030, growing at a CAGR of 6.80% from 2023 to 2030.
The market for IHC and IHS (Immunohistochemistry and In Situ Hybridization) slide staining systems is expected to grow as healthcare gets better and more tools for diagnosing diseases, like karyotyping, become available. IHC and ISH are important ways to color slides that help find proteins and genes in tissues. In these methods, antibodies or probes are used to bind to certain proteins or genes, which can then be seen in a number of ways. This lets scientists find out where proteins and genes are in cells and how they are produced.
Over the next few years, the market is expected to be driven in large part by the growing use of automation and machine learning in IHC, as well as the launch of technologically advanced IHC products. IHC is much better at spotting diseases now that the way it is done has been changed. The market is also rising because more products are getting approved and more high-tech IHC methods for diagnosing diseases are being released.
For instance, in August 2022, the FDA cleared Roche's VENTANA MMR RxDx Panel to find dMMR solid tumor patients who are good candidates for anti-PD-1 immunotherapy. Companies keep making new products to improve their place on the market, which helps them make money. For example, in March 2022, Roche released the DISCOVERY Green HRP kit to find biomarkers and cell groups in tissue-based studies and make a profile of them. This kit can be used with other detection kits to make in situ hybridization and immunohistochemistry (IHC) better at doing multiplexing. The immunohistochemistry method can only rate a sample based on a single parameter.
With newer techniques, like multiplexed IHC, it is possible to do a detailed and multiparametric study on a single piece of tissue by using advanced mass spectrometric detection methods. Multiplexed IHC helps fix the technical problems that the labeled fluorescence detection-based method brings up, which boosts the market's income. The market would gain from the rising number of older people in both developed and developing countries. As the number of older people in the world grows dramatically, it is possible that the number of age-related disorders will rise dramatically. With RT-PCR, IHC, and an electron microscope, the virus was found. This shows that SARS-CoV-2 affects more than just the lungs.
With these tools, automatic staining can be done faster, better, and more cheaply. This helps each test be more useful. The IHC and IHS slide staining systems market in the world is divided by type, use, and location. Based on what they are, the market is divided into platforms, tools, reagents, and consumables. By how they are used, the market for immunohistochemistry and in situ hybridization slide labeling systems is split into drug manufacturing, pathology research, and identifying diseases.
Market Dynamics
Trend: The IHC and IHS Slide Staining Systems Market Around the World
The major reason why the global market for IHC and IHS is growing is because more money is being spent on healthcare. Over the next few years, the rise in cancer cases around the world will also help the market grow. Also, more money will be spent on pathophysiology study and more automation will be used in diagnostics, which will help this field grow in the coming years. On the other hand, the fact that there are now a lot of players in this market and that the prices of ISH and IHC slide staining systems are going up may make it hard for the market to grow.
Growth Factors
-
IHC and ISH slide staining systems are in higher demand as a result of the increasing incidence of cancer and other diseases.
-
IHC and ISH slide staining devices have made technological advances that improve performance, accuracy, and effectiveness.
-
IHC and ISH slide staining systems are being used by an increasing number of study institutions and labs for their studies.
-
There is an increasing need for personalized medicine, which calls for precise diagnosis using IHC and ISH slide staining methods.
Major Market Segments Covered
On the basis of Type
Systems
IHC and ISH tools for staining slides for histology have a few advantages over the old methods. First of all, they are easy and quick to use, which makes them great for everyday histology. Second, they are very precise and accurate, making it easy to find certain kinds of cells. Lastly, IHC and ISH slide labeling methods are gentler on tissue than traditional methods. This means that they can be used on more fragile samples without hurting them or losing information.
Accessories
IHC and ISH slide labeling devices come with things like slides, coverslips, buffers, dyes, and mounting media. These extras make the system run better and easier to use. Using these tools can help prevent contamination and make sure that the results are right.
Consumables
The chemicals that are used to color the slides in IHC and ISH slide staining devices are called consumables. There are some colors, filters, and other chemicals among these. Consumables are good for these systems because they work well and don't need to be changed very often.
Reagents
In IHC and ISH slide labeling, reagents are chemicals that help find certain proteins or cells. These chemicals can be used to stain different kinds of tissue, and they often have properties that make them useful for certain kinds of research. For example, you can use antibodies to find certain proteins and colors to find certain cells.
On the basis of Application
Drug Manufacturing
Researchers require large amounts of stained samples for their studies which drives growth globally every year because its start to finish in 2022 by giving various reagents & materials through national collaborations & private funding initiatives supported by government agencies, non-profit organizations, foundations & companies
Pathology Research
Pathology research is expected to grow at a profitable rate during the forecast time period, since more and more pathologists are working on research projects all over the world.
Disease Detection
As the need for quick testing tools grows, it took the most time in 2015 to figure out what diseases. Over the next few years, more people are likely to get long-term diseases like cancer and diabetes. This will make IHC and ISH even more important as ways to diagnose.
Regional insights
Geographically, the IHC and IHS Slide Staining Systems market has been looked at in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. (MEA).
The world market is divided into North America, Asia-Pacific, Europe, Latin America, and the Middle East and Africa based on where they are. In 2022, North America had the biggest part of the market and made more than 38.5% of all the money made around the world. The number of big players, how easy it is to get IHC solutions, how many technologically advanced IHC tools are used, and how many new IHC solutions come out are all important factors that affect the growth of the regional market.
In 2019, North America had the biggest sales share on the world market. Some of the things that add to this large share are a well-established healthcare infrastructure, a high rate of adoption of advanced diagnostic technologies, and a growing demand for personalized healthcare. During the time frame of the forecast, the number of people with cancer and other long-term diseases is also likely to rise in the area. This is because genes can be changed by bad habits and pollution in the surroundings. This is likely to make more people want to buy the goods over the next few years. This is because economic growth has led to more money in people's pockets, better health care facilities and infrastructure, and government attempts to find and treat diseases like cancer and heart disease earlier.
Scope Of Report
Report Attribute | Details |
Study Period | 2017-2030 |
Base Year | 2022 |
Estimated year | 2023 |
Forecast period | 2023-2030 |
Historic Period | 2017-2022 |
Units | Value (USD Billion) |
Growth Rate | CAGR of 6.8% from 2023 to 2030 |
By Type |
|
By Application |
|
By Companies |
|
Regional Scope |
|
Reasons to Purchase this Report and Customization Scope | 6-month post-sale analyst assistance.10% Free Customization and 15 Company Profiles in addition to the ones specified |
Key vendors
- Biocare Medical
- BioGenex Laboratories
- Celerus Diagnostics
- Dako A/S
- Leica Biosystems Nussloch GmbH
- F. Hoffmann-La Roche Ltd.
- Thermo Fisher Scientific Inc. and others.
-
Biocare Medical
Biocare Medical LLC makes the full range of reagents for IHC and in situ hybridization (ISH; RISH) tests, as well as automatic immunohistochemistry (IHC) instruments. Biocare came up with multiplex IHC detection, which speeds up turn-around times, increases instrument output, and cuts reagent use and costs by at least 50%.
- BioGenex Laboratories
BioGenex designs, makes, and sells advanced, fully automated molecular pathology tools that can be used to diagnose and predict cancer, as well as for personalized medicine and life science research. Their new eFISHency integrated workflow solution for FISH labs and miRNA system for characterizing cancer of unknown primary (CUP) and undifferentiated tumors is a game-changer that has no equal in the business. Their fully automated molecular pathology workstations are the most advanced machines in the world. Their focus on the customer, great help after the sale, and excellent professional service make them the best in their field when it comes to customer service. Their innovative spirit lets us give cutting-edge technology that is years ahead of their competitors and the best systems for life science research and diagnostics.
- Dako A/S
Dako is owned by Agilent Technologies. Agilent's Dako brand of pathology solutions, which include reagents, instruments, software, and knowledge, are used by hospitals and research labs all over the world to make accurate diagnoses based on tissue samples and choose the best way to treat cancer patients.
- Leica Biosystems Nussloch GmbH
Leica Biosystems is a leader in workflow solutions and a provider of cancer diagnostics. It has the most full set of tools, from biopsies to diagnoses, of any company in its field. Their goal, "Advancing Cancer Diagnostics, Improving Lives," is at the heart of how they do business. Their goods are easy to use and can be counted on, which helps improve workflow and diagnostic accuracy.
- Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is the market leader in offering services to the scientific community. It makes about $40 billion in sales every year. Their goal is to give our people the tools they need to make the world safer, healthier, and better for the environment. They are here to help their customers, whether they are trying to speed up life sciences research, solve hard analytical problems, increase lab output, improve patient health through diagnostics, or come up with and make treatments that can change people's lives. Through industry-leading names like Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD, their global team offers an unbeatable mix of cutting-edge technologies, easy shopping, and pharmaceutical services.
- F Hoffmann-La Roche Ltd.
Roche, a leading health care company, has been researching, developing, making, and selling health care goods for more than a hundred years. Their products and services are all about diagnosing, treating, and preventing sickness, which is good for health and quality of life.
Market Segmentation
The IHC and ISH slide staining system Market research report is categorized based on type, applications and region
On the basis of Type
- Systems
- Accessories
- Consumables
- Reagents
On the basis of Application
- Drug Manufacturing
- Pathology Research
- Disease Detection
Global IHC and ISH slide staining system market Regional insights
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- France
- Italy
- Spain
- UK
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia-Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Conclusion
The study gives a lot of information about how new market trends, drivers, growth opportunities, and restraints may affect the industry. It gives a full look at each market segment, including information about products, how they are used, and competitors. Systems IHC and ISH Stains on Slides Market research studies keep a close eye on the top competitors by looking at strategy analysis, micro and macro market trends and scenarios, pricing analysis, and a full summary of how the market will be in the future. Based on where the companies are, the industry is split into North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa. (MEA). It is a thorough study done by experts that looks at the main and secondary drivers, market share, top segments, and geographic analysis. The study also looks at the most important players, relationships, mergers, and acquisitions, as well as the best-known ideas and ways of doing business.